The preliminary consolidated results for 2020 confirm the Group’s growth capacity even in the current global public health emergency. The growth is mainly attributable to the increase in sales of highly innovative solutions, to the international expansion, and to the increase of private customers.
Video webacast, Tuesday 1st April 2025 – 15:00 CET
Revenue € 510 M, EBITDA € 105 M
Un sistema centralizzato per gestire, proteggere e valorizzare i dati sanitari: ecco come funziona l'EDS e quali opportunità offre.
We have deep roots, developed through 35 years of history. Competence, experience and passion guide our present and push us towards the future.
